EGEIRO Pharma (XPAR:ALVET) Other Current Receivables : €0.36 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is EGEIRO Pharma Other Current Receivables?

EGEIRO Pharma's Other Current Receivables for the quarter that ended in Dec. 2023 was €0.36 Mil.

EGEIRO Pharma's quarterly Other Current Receivables declined from Dec. 2022 (€0.25 Mil) to Jun. 2023 (€0.25 Mil) but then increased from Jun. 2023 (€0.25 Mil) to Dec. 2023 (€0.36 Mil).

EGEIRO Pharma's annual Other Current Receivables declined from Dec. 2021 (€0.32 Mil) to Dec. 2022 (€0.25 Mil) but then increased from Dec. 2022 (€0.25 Mil) to Dec. 2023 (€0.36 Mil).

EGEIRO Pharma Other Current Receivables Historical Data

The historical data trend for EGEIRO Pharma's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EGEIRO Pharma Other Current Receivables Chart

EGEIRO Pharma Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Receivables

0.01

0.17

0.32

0.25

0.36

EGEIRO Pharma Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Other Current Receivables	Get a 7-Day Free Trial					0.44	0.25	0.25	0.36	-

EGEIRO Pharma Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

EGEIRO Pharma Other Current Receivables Related Terms

Thank you for viewing the detailed overview of EGEIRO Pharma's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

EGEIRO Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EGEIRO Pharma (XPAR:ALVET) » Definitions » Other Current Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Avenue Jean Mermoz 32/1, Gosselies, BEL, 6041

Website

https://www.egeiro.be

EGEIRO Pharma is a biopharmaceutical company. The company is focused on the clinical development of drugs for Idiopathic Pulmonary Fibrosis, a chronic, devastating, and fatal disease characterized by the deterioration of lung function.

EGEIRO Pharma Headlines

No Headlines